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The increasing number of cardiac reoperations has forced
the development of pericardial substitutes to avoid pericardial
adhesions resulting from the first operation. Experimental
studies have investigated the effect of a biodegradable colla-
gen-elastin patch on preservation of the heart anatomy and
pericardium regeneration.1 With this collagen-elastin patch,
pericardial adhesions in experimental animals were mini-
mized; separation of the different structures without restric-
tion was allowed, and the visibility of coronary arteries was
preserved. The small peptides released during the degradation
of the collagen-elastin complex reduce the elastase and colla-
genase activity and minimize local inflammatory reaction.1-3
Collagen-elastin resorption occurs simultaneously with the
synthesis of a neopericardium, and the patch acts as a scaffold
for the growth of mesothelium-like cells.1,3 However, no clin-
ical experience exists about the tolerance of this collagen-
elastin patch in adult cardiac operations.
The present report shows the initial and medium-term
results of the tests of tolerance and biocompatibility per-
formed in a series of patients included in the clinical trial per-
formed at the University Hospital of Valladolid.
From December 1995 to April 1997, 25 patients with a
mean age 55.6 years (range, 41 to 74 years) who underwent
coronary artery bypass grafting received the biodegradable
collagen-elastin patch (OVI S A, Martillac, France) as a peri-
cardial substitute. This patch is made of a complex of bovine
elastin (Elastin Products Company, Inc, Avensville, Mo) and
bovine collagen (Coletica, Lyon, France) reinforced with a
resorbable polygycolate mesh. The patch was applied before
sternal closure (covering as smoothly as possible the anterior
wall of the right ventricle, the right atrium, pulmonary artery,
ascending aorta, and grafts) and held in place by interrupted
5-0 monofilament stitches to the edge of the native pericardi-
um. Two drains were placed into the mediastinum, one under
the patch and the other into the left pleural cavity. A group of
12 patients with a mean age of 57 years (range, 47 to 75 years)
who underwent coronary artery bypass grafting without the
use of the collagen-elastin patch were considered as control.
Demographic and clinical data included age, sex, postoperative
fever, wound infection, and hospital stay. Biocompatibility tests
included peripheral blood examination, serum protein determina-
tion, erythrocyte sedimentation rate, plasma reactive c protein,
and a 1-antitrypsin. Acoustic properties of the patch and systolic
and diastolic function of the heart were studied by transthoracic
Doppler echocardiography. Radioisotopic image evaluation of
the mediastinum with leukocytes labeled with technetium
Tc 99m-hexamethylpropylenamine-oxine was performed. Ana-
lytical, structural, and functional explorations were carried out
on postoperative day 8 and postoperative months 2 and 6.
No statistically significant differences were observed between
groups when demographic, clinical, radioisotopic, or echocar-
diographic characteristics (Student t test) were compared.
Transthoracic ultrasound examination showed normal cardiac
structures. No significant changes of systolic ventricular func-
tion were observed. A normal pattern of diastolic ventricular fill-
ing was confirmed in all patients. No significant pericardial effu-
sion could be observed. Radioisotopic studies did not reveal any
difference between the 2 groups, suggesting that there is no sig-
nificant accumulation of leukocytes around the path.
These preliminary clinical results suggest that the collagen-
elastin patch shows an excellent tolerance without increasing
the postoperative local and systemic inflammatory responses
to cardiac surgery. Physical characteristics of the patch did not
interfere with the acoustic properties of the heart nor with
diastolic or systolic ventricular function.
On the basis of our preliminary clinical experience, the col-
lagen-elastin patch seems to be biocompatible without notice-
able secondary effects. To date no patient has required reop-
eration. However, future studies will give further information
on biologic tissue modifications and on interaction between
the biodegradable patch and cardiac structures.
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